Allied Market Research
Viral Vector And Plasmid Dna Market

Viral Vector and Plasmid DNA Market

Size, Share, Competitive Landscape and Trend Analysis Report by Product Type (Plasmid DNA, Viral Vector, Non Viral Vector), by Application (Cancer, Genetic Disorder, Others) and by End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A13614
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


Viral vectors are commonly used tools by molecular biologists delivering genetic materials into cells. The specialized molecular mechanisms are evolved by viruses for efficient transport of their genomes inside the cells that are infected by them with the process of transduction.

Viral vectors and plasmid DNA can be applied in gene therapy to treat different diseases such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Being based on baculovirus, herpes simplex viruses, adenoviruses, and others, viral vectors are finding greater application in vaccinology and novel drug development. Vectors should be modified to provide safe handling (no production of new virions in a host) and low toxicity (no effect on the physiology of the normal host cell). They should also be stable (no rearrangement of the genome), and for manufacturing, it is important that the viral vector is easily quantified and that it lends itself to large-scale production.

COVID-19 Impact analysis

The COVID-19 epidemic has opened up significant opportunities for market players. For example, in December 2020 and February 2021, multinational pharmaceutical companies such as AstraZeneca and Janssen Pharmaceuticals developed COVID-19 viral vector-based vaccines, respectively. Aside from these firms, several viral vector-based vaccines are now in development. As a result, demand for viral vectors has increased, resulting in increased revenue for viral vector manufacturers due to the COVID-19 pandemic. 

Top Impacting Factors

  • There is an increase in the need for viral vector and plasmid DNA production due to rise in multiple genetic disorders and various cancers.
  • Furthermore, factors such as technological advancements to address challenges posed by traditional vector production methods, surge in the number of clinical studies, and rise in number of gene therapy candidates, combined with their rapid progression through various stages of clinical development propel the demand for viral vector and plasmid DNA manufacturing.
  • The expansion of the viral vectors and plasmid DNA manufacturing market is fueled by a rise in funding for gene therapy R&D activities and an increase in public awareness about gene therapy.
  • Furthermore, the rise in demand for synthetic genes and the untapped expanding market potential are projected to open up new opportunities for market players during the forecast period.
  • However, high expense of gene therapies, as well as the risk of mutagenesis and other barriers to gene therapy limits the market expansion.

Market Trends

New product launches to flourish the market

In 2018, UniQure Biopharma BV sponsored for the trial of AMT-061 in severe or moderately severe Hemophilia B patients, and AMT-061 is a recombinant adeno-associated viral vector.

In March 2021, the U.S. FDA approved ABECMA (idecabtagene vicleucel), a lentivirus-based gene therapy to treat R/R multiple myeloma. With the increasing gene therapy approvals and consequent increase in manufacturing capabilities, the competition in this arena is anticipated to intensify in the near future.

in April 2021, Albumedix extended research collaboration with Cobra Biologics for the upstream and downstream processing of AAV and lentiviral vector. Collaboration is intended for stability enhancement and process optimization.

Key Benefits of the Report

  • This study presents the analytical depiction of the Viral Vector and Plasmid DNA along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Viral Vector and Plasmid DNA market share.
  • The current market is quantitatively analyzed to highlight the Viral Vector and Plasmid DNA market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed Viral Vector and Plasmid DNA market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Viral Vector and Plasmid DNA Report

  • Who are the leading market players active in the Viral Vector and Plasmid DNA market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
  • What is "Viral Vector and Plasmid DNA"?
  • What is "Viral Vector and Plasmid DNA" Market prediction in the future?
  • Who are the leading global players in the "Viral Vector and Plasmid DNA" Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "Viral Vector and Plasmid DNA" Market report?

Viral Vector and Plasmid DNA Market Report Highlights

Aspects Details
By Product Type
  • Plasmid DNA
  • Viral Vector
  • Non Viral Vector
By Application
  • Cancer
  • Genetic Disorder
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Cell and Gene Therapy Catapult, Novasep, CobraBiologics, Diosynth Ltd., Kaneka Eurogentec, Inc., Lonza, FUJIFILM, Spark Therapeutics, Inc., Merck KGaA, UniQure N.V.

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
Related Tags

Purchase Full Report of
Viral Vector And Plasmid Dna Market

Start reading.
This Report and over 71,215+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690  $3,321
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930  $3,537
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820  $4,947
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540  $5,559
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870  $7,896
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports
*Terms and Conditions Apply

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers